Inicio › Cáncer de endometrio › Míchigan › Detroit
Ensayos clínicos de Cáncer de endometrio en Detroit, MI
21 estudios para Cáncer de endometrio buscan participantes en centros de Detroit y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
ReclutandoFase 3
- Wayne State University/Karmanos Cancer Institute, Detroit
Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
ReclutandoFase 1/2
- Research Site, Detroit
Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer
ReclutandoEstudio observacional
- Henry Ford Health, Detroit
A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab
ReclutandoFase 1/2
- Karmanos Cancer Institute, Detroit
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
ReclutandoFase 1
- Barbara Ann Karmanos Cancer Institute, Detroit
A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors
ReclutandoFase 1/2
- GSK Investigational Site, Detroit
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
ReclutandoFase 1
- Karmanos Cancer Institiute, Detroit
Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
ReclutandoFase 1
- Karmanos Cancer Institute, Detroit
A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma
ReclutandoFase 2
- Karmanos Cancer Institute, Detroit
A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors.
ReclutandoFase 1
- Karmanos Cancer Center, Detroit
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
ReclutandoFase 1/2
- Karmanos Cancer Institute, Detroit
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
ReclutandoFase 1/2
- Karmanos Cancer Institute, Detroit
Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors
ReclutandoFase 1
- Investigative Site #120, Detroit
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
ReclutandoFase 1
- Karmanos Cancer Institute, Detroit
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
ReclutandoFase 1/2
- Henry Ford Health Hospital, Detroit
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
ReclutandoFase 1
- Karmanos Cancer Institute, Detroit
Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
ReclutandoFase 1
- Henry Ford Cancer Institute, Detroit
A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Endometrial Cancer.
ReclutandoFase 2
- Barbara Ann Karmanos Cancer Hospital, Detroit
A Beta-only IL-2 ImmunoTherapY Study
ReclutandoFase 1/2
- Karmanos Cancer Institute, Detroit
BP1001-A in Patients With Advanced or Recurrent Solid Tumors
ReclutandoFase 1
- Karmanos Cancer Institute, Detroit
A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies
ReclutandoFase 1/2
- Barbara Ann Karmanos Cancer Hospital dba Karmanos Cancer Center, Detroit
Ensayos de Cáncer de endometrio en otras ciudades
- Houston, TX68 estudios
- New York City, NY52 estudios
- Boston, MA50 estudios
- Arlington, VA39 estudios
- Nashville, TN38 estudios
- Los Angeles, CA34 estudios
- St. Louis, MO29 estudios
- Philadelphia, PA28 estudios
- San Antonio, TX27 estudios
- Columbus, OH25 estudios
- Chicago, IL25 estudios
- Oklahoma City, OK25 estudios
Otros estudios en Detroit
- Cáncer de pulmón de células no pequeñas44 estudios
- Cáncer de seno33 estudios
- Cáncer (todos los tipos)29 estudios
- Cáncer del colon y del recto26 estudios
- Cáncer de ovario26 estudios
- Cáncer metastásico24 estudios
- Cáncer de próstata22 estudios
- Cáncer de pulmón20 estudios
- Mieloma múltiple19 estudios
- Cáncer de estómago16 estudios
- Carcinoma de células escamosas de cabeza y cuello15 estudios
- Leucemia mielógena aguda14 estudios
De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.